Loading...

CNTX CONTEXT THERAPEUTICS INC Delisting Actions 8-K Filing

CNTX

CNTX

CONTEXT THERAPEUTICS INC

(CNTX)

2025 8-K

Summary

Summary

Nasdaq Extension Granted

Reverse Stock Split

Investor Meetings

Clinical Trial Update

Nasdaq Notification

Clinical Trial Update

License Agreement

Board Appointments

Annual Meeting of Stockholders

Private Placement

FDA IND Application Submission

Bylaws Amendment

Amendment of Collaboration ...

Press Release and Corporate...

Regulation FD Disclosure

Compliance with Minimum Bid...

Annual Meeting of Stockholders

Financial Results and Disco...

Regulation FD Disclosure

Press Release and Corporate...

External Links:

On August 28, 2025, Context Therapeutics Inc. received a 180-day extension from Nasdaq to comply with the Minimum Bid Price Rule, moving the deadline to February 23, 2026, after previously failing to meet the $1.00 share price requirement.

AI Assistant

CONTEXT THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.